Voya Investment Management LLC increased its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 5.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 102,216 shares of the company’s stock after purchasing an additional 5,525 shares during the quarter. Voya Investment Management LLC’s holdings in HCA Healthcare were worth $10,488,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. FMR LLC increased its position in HCA Healthcare by 54.9% during the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after purchasing an additional 1,944,961 shares in the last quarter. LSV Asset Management increased its position in HCA Healthcare by 9.2% during the 2nd quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after purchasing an additional 457,752 shares in the last quarter. Schwab Charles Investment Management Inc. increased its position in HCA Healthcare by 5.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,222,343 shares of the company’s stock worth $125,413,000 after purchasing an additional 64,426 shares in the last quarter. Renaissance Technologies LLC increased its position in HCA Healthcare by 187.9% during the 2nd quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock worth $112,289,000 after purchasing an additional 714,331 shares in the last quarter. Finally, Swiss National Bank increased its position in HCA Healthcare by 1.9% during the 2nd quarter. Swiss National Bank now owns 926,222 shares of the company’s stock worth $95,030,000 after purchasing an additional 17,500 shares in the last quarter. 70.40% of the stock is owned by hedge funds and other institutional investors.
In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,689 shares of the company’s stock in a transaction that occurred on Wednesday, July 25th. The stock was sold at an average price of $112.53, for a total value of $190,063.17. Following the transaction, the senior vice president now directly owns 10,057 shares of the company’s stock, valued at approximately $1,131,714.21. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Victor L. Campbell sold 22,782 shares of the company’s stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $127.12, for a total value of $2,896,047.84. Following the completion of the transaction, the senior vice president now directly owns 202,650 shares in the company, valued at $25,760,868. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 170,257 shares of company stock worth $21,118,053. 2.80% of the stock is currently owned by corporate insiders.
HCA has been the subject of a number of recent research reports. Mizuho reiterated a “buy” rating and set a $145.00 price objective on shares of HCA Healthcare in a research report on Thursday, August 2nd. Jefferies Financial Group reiterated a “buy” rating and set a $135.00 price objective on shares of HCA Healthcare in a research report on Thursday, July 26th. SunTrust Banks lifted their price target on HCA Healthcare to $145.00 and gave the company a “buy” rating in a report on Thursday, July 26th. Cantor Fitzgerald restated a “buy” rating and issued a $115.00 price target on shares of HCA Healthcare in a report on Friday, July 20th. Finally, ValuEngine upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Wednesday, July 18th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $135.19.
HCA Healthcare stock traded up $1.43 during midday trading on Friday, hitting $133.86. 1,454,880 shares of the company were exchanged, compared to its average volume of 1,908,900. The firm has a market capitalization of $48.14 billion, a PE ratio of 20.31, a price-to-earnings-growth ratio of 1.23 and a beta of 0.49. The company has a debt-to-equity ratio of -7.64, a quick ratio of 1.15 and a current ratio of 1.36. HCA Healthcare Inc has a fifty-two week low of $71.18 and a fifty-two week high of $141.11.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 EPS for the quarter, topping the consensus estimate of $2.16 by $0.13. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The firm had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. During the same period in the previous year, the company posted $1.73 EPS. HCA Healthcare’s revenue for the quarter was up 7.4% on a year-over-year basis. On average, analysts forecast that HCA Healthcare Inc will post 9.23 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, September 28th. Shareholders of record on Tuesday, September 4th were given a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date was Friday, August 31st. HCA Healthcare’s payout ratio is 21.24%.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: Should You Consider an Index Fund?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.